avoparcin has been researched along with olaquindox* in 1 studies
1 other study(ies) available for avoparcin and olaquindox
| Article | Year |
|---|---|
Effects of growth-promoting antimicrobials on inhibition of Yersinia enterocolitica O:3 by porcine ileal microflora.
The survival of Yersinia enterocolitica serotype O:3 was examined in an in vitro model of the porcine ileum in the presence of normal ileal microflora using a medium supplemented with the growth-promoting antimicrobials avoparcin, spiramycin, tylosin, carbadox and olaquindox, or without any antimicrobials, at 39 degrees C for 5 d. Growth of Y. enterocolitica was inhibited in all trials in the following order: avoparcin < carbadox < spiramycin < no feed additives < tylosin < olaquindox. The media supplemented with avoparcin, carbadox and spiramycin supported the survival of Y. enterocolitica up to 5 d. When incubated with the normal ileal microflora without any growth-promoting antimicrobials, Y. enterocolitica could not be isolated after 4 d. With olaquindox and tylosin, Y. enterocolitica was not detected after 3 d. Topics: Animals; Anti-Bacterial Agents; Colony Count, Microbial; Glycopeptides; Ileum; Microbial Sensitivity Tests; Palatine Tonsil; Quinoxalines; Swine; Yersinia enterocolitica | 1998 |